Philip R. Harper, 10% Owner at Aevi Genomic Medicine, Inc. (GNMX), bought 20,470 shares at $1.19 ($24K) on 2017-08-10, disclosed to the SEC on 2017-08-14.
Open-market purchase of $24k GNMX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| GNMX | BUY | 2017-03-27 | $2.0M | — | Filing → |
| ACAS | SELL | 2015-12-04 | $1.1M | — | Filing → |
| ACAS | SELL | 2015-03-13 | $577K | — | Filing → |